Home-based Care and Hand Hygiene Interventions in Honduras
Implementation and Evaluation of Home-based Care and Hand Hygiene Interventions in Honduras
1 other identifier
interventional
1,821
1 country
1
Brief Summary
This study aims to enroll patients with acute infection with Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) who do not meet criteria for hospital admission according to protocols developed by the Honduras Ministry of Health (MOH). Patients who are triaged to home must also be over the age of 60 years or have one high risk comorbidity and be over 45 years in order to meet inclusion criteria. These patients will be randomly assigned to one of four home-based care strategies, which may or may not include regular blood oxygenation monitoring and provision of alcohol-based hand-rub. Patients will be followed until resolution of their acute illness, and data will be collected on feasibility, impact and acceptance of the intervention. Some patients will be followed for up to one year to monitor for post-Coronavirus Disease 2019 (COVID-19) symptoms.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable covid19
Started Mar 2022
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
May 10, 2021
CompletedFirst Posted
Study publicly available on registry
May 14, 2021
CompletedStudy Start
First participant enrolled
March 31, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 15, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
February 28, 2023
CompletedMay 14, 2025
May 1, 2025
10 months
May 10, 2021
May 9, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (4)
Disposition after referral
Disposition (home, admission, other) for those referred to a higher level of care
28 days
Duration of hospitalization
Duration of hospitalization (days) for those who are admitted
90 days
Duration of ICU and/or ventilator requirement
Duration of ICU and/or ventilator requirement (days) for those requiring critical care
90 days
Mortality
Death prior to discharge from acute COVID-19 monitoring
90 days
Other Outcomes (11)
Proportion that receive the prescribed follow-up plan
28 days
Proportion with complete pulse oximetry data
28 days
Loss to follow-up
90 days
- +8 more other outcomes
Study Arms (4)
Phone-based monitoring without blood oxygenation monitoring with ABHS
EXPERIMENTALStudy staff will perform daily phone-based assessments using standardized electronic study tools (tablets). Clinical features will be documented on a phone-based patient monitoring form. Subjects will received a home-based care kit that contains alcohol-based hand sanitizer (ABHS).
Phone-based monitoring without blood oxygenation monitoring without ABHS
EXPERIMENTALStudy staff will perform daily phone-based assessments using standardized electronic study tools (tablets). Clinical features will be documented on a phone-based patient monitoring form. Subjects will received a home-based care kit that does not contain alcohol-based hand sanitizer.
Phone-based monitoring with blood oxygenation monitoring with ABHS
EXPERIMENTALStudy staff will perform daily phone-based assessments using standardized electronic study tools (tablets). Clinical features and oxygen saturation levels will be documented on a phone-based patient monitoring form. Oxygen saturation level will be assessed four times per day (morning, midday, evening, plus during the phone-based assessment) by the patient and/or family member and the lowest stable (i.e. without substantial fluctuations) level recorded during a monitoring period of one minute will be recorded and registered. Patient's will be provided monitoring sheets to record the times and dates of the oxygen saturation levels. Subjects will received a home-based care kit that contains alcohol-based hand sanitizer.
Phone-based monitoring with blood oxygenation monitoring without ABHS
EXPERIMENTALStudy staff will perform daily phone-based assessments using standardized electronic study tools (tablets). Clinical features and oxygen saturation levels will be documented on a phone-based patient monitoring form. Oxygen saturation level will be assessed four times per day (morning, midday, evening, plus during the phone-based assessment) by the patient and/or family member and the lowest stable (i.e. without substantial fluctuations) level recorded during a monitoring period of one minute will be recorded and registered. Patient's will be provided monitoring sheets to record the times and dates of the oxygen saturation levels. Subjects will received a home-based care kit that does not contain alcohol-based hand sanitizer.
Interventions
Study staff will perform daily phone-based assessments using standardized electronic study tools (tablets). Clinical features will be documented on a phone-based patient monitoring form.
Oxygen saturation will be monitored and recorded at regular intervals.
Alcohol-based hand sanitizer will be distributed to subjects.
Eligibility Criteria
You may qualify if:
- Patients presenting with acute infection with SARS-CoV-2.
- Patients test positive for SARS-CoV-2 with rapid antigen test.
- Patients triaged to HBC by SESAL clinicians according to existing SESAL policies and protocols.
- Greater than 60 years of age OR greater than 45 years AND at least one comorbidity which increases risk for poor outcomes due to COVID-19.
- Live or work in the city where the study is being implemented
- Agrees to participate and signs informed consent
You may not qualify if:
- Less than 45 years of age
- Incapable of giving assent to participate due to medical condition at the time of enrollment
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Brigham and Women's Hospitallead
- Centers for Disease Control and Preventioncollaborator
- Ministry of Health, Hondurascollaborator
Study Sites (1)
COVID-19 Triage Centers
Tegucigalpa, Francisco Morazán Department, Honduras
Related Publications (1)
Roberts KW, Alvarez B, de St Aubin M, Diaz O, Garnier S, Schnorr CD, Cruz S, Pavon L, Ochoa A, See R, Medice S, Santos HM, Ochoa J, Solis S, Dumas D, Baldwin M, Martinez A, Hakim A, Nilles E. Impact of self-administered pulse oximetry among non-hospitalized patients at risk of severe COVID-19 in Honduras: A pragmatic, cluster-randomized trial with temporal clustering. PLOS Glob Public Health. 2025 Nov 7;5(11):e0004618. doi: 10.1371/journal.pgph.0004618. eCollection 2025.
PMID: 41202024DERIVED
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- HEALTH SERVICES RESEARCH
- Intervention Model
- FACTORIAL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Assistant Professor
Study Record Dates
First Submitted
May 10, 2021
First Posted
May 14, 2021
Study Start
March 31, 2022
Primary Completion
January 15, 2023
Study Completion
February 28, 2023
Last Updated
May 14, 2025
Record last verified: 2025-05